AI Articles and Analysis about Research and development

Episode Summary: This week on AI in Industry, we speak with Amir Saffari, Senior Vice President of AI at BenevolentAI, a London-based pharmaceutical company that uses machine learning to find new uses for existing drugs and new treatments for diseases.

AI and machine learning software are beginning to integrate themselves as tools for efficiency and accuracy within pathology. According to a March 2018 digital pathology report produced by Allied Market Research, such software enables the “procurement, management and interpretation” of information and can be applied to multiple functions within the field of healthcare.

Artificial intelligence has already established a small but growing presence in the life sciences industry today, starting with drug discovery and development and now in emerging applications across the product life cycle.

Episode Summary: This episode explores the ways in which artificial intelligence has the potential to revolutionize the field of medicine. This week's guest, Turbine.ai's Dr. Kristóf Zsolt Szalay speaks to this topic, discussing research that hopes to create automated learning networks and algorithms designed to predict the development of human cells in response to drugs. This technological innovation would make it possible for near-instantaneous simulations to be run, allowing optimal combinations and optimal doses of drugs to be pinpointed and distributed to patients.

Episode summary: In this episode, we talk to Murali Aravamudan, Founder and CEO of AI-driven drug discovery startup Qrativ, a joint venture by the Mayo Clinic and biotech/data science firm nference. Murali and I discuss the surge of medical information and data in the medical industry, the role of artificial intelligence in developing drugs for treatments to various diseases, and the future of AI in drug discovery.

Discovering a new drug is a long, expensive and often haphazard process. Thousands of compounds are subject to a progressive series of tests, and only one might turn out to be a viable drug. Any tool which can speed up just one of these steps in this long multi-step process would have big implications down the entire chain. This is why some of the largest pharmaceutical companies are turning to AI to help the process.

Genomics is a branch of molecular biology focused on studying all aspects of a genome, or the complete set of genes within a particular organism. Today, machine learning is playing an integral role in the evolution of the field of genomics.

Episode summary: Machine learning currently faces a number of obstacles which prevent it from advancing as quickly as it might. How might these obstacles be overcome and what impact would this have on the machine learning across different industries in the coming decade? In this episode we talk to Dr. Hanie Sedghi, Research Scientist at the Allen Institute for Artificial Intelligence, about the developments in core machine learning technology that need to be made, and that researchers and scientists are working, on to further the application of machine learning in autonomous vehicles.